Anebulo Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Anebulo Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2021 to Q3 2024.
  • Anebulo Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 25.9M shares, a 1.17% increase year-over-year.
  • Anebulo Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 25.8M shares, a 2.98% increase from 2023.
  • Anebulo Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 25.1M shares, a 7.41% increase from 2022.
  • Anebulo Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 23.3M shares, a 71.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 25.9M +300K +1.17% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 25.8M +748K +2.98% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-25
Q1 2024 25.9M +300K +1.17% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 25.8M +157K +0.61% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 25.6M +2.22M +9.47% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 25.1M +1.73M +7.41% Apr 1, 2023 Jun 30, 2023 10-K 2024-09-25
Q1 2023 25.6M +2.29M +9.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 25.6M +2.29M +9.8% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 23.4M +71.9K +0.31% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 23.3M Apr 1, 2022 Jun 30, 2022 10-K 2023-09-22
Q1 2022 23.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 23.3M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 23.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.